Invenio Imaging Announces Completion of Enrollment in Landmark Study of AI-Based Image Analysis for Lung Cancer
Source: PRNewswire· August 3, 2026
SynaBot summary
Invenio Imaging has finished enrolling patients in its ON-SITE study, a critical U.S. trial for its AI-powered NIO® Lung Cancer Reveal system. This technology analyzes fresh tissue images to detect lung cancer.
Key takeaways
- AI system analyzes fresh lung tissue for cancer detection
- Pivotal U.S. study has completed patient enrollment
- Technology aims for faster diagnostic results
- Potential to accelerate cancer treatment initiation
Why it matters
This AI tool could significantly speed up lung cancer diagnosis by providing rapid analysis of tissue samples. Faster, more accurate results mean patients can begin treatment sooner, potentially improving outcomes.
This story was reported by PRNewswire. Read the full original article:
Read on PRNewswire Try this on SynaBot
Related AI assistants, prompts, and tools from the SynaBot catalog.
AI Assistants
AI Tools
- StudyableLooking for a education tool to tutor learners, generate practice materials, explain concepts, and support study workflows? Studyable handles revolutionize learning: AI summaries, custom flashcards, progress tracking, collaborative tools — see the full review below.
- StudyCrumbStudyCrumb — Transform text instantly; ensure uniqueness, free unlimited access. It sits in the hr & recruiting category and is built to assist with sourcing, screening, interview prep, onboarding content, and internal HR processes.
